About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Synthetic Vaccine To Protect Against Mayaro Virus Created

by Rishika Gupta on February 9, 2019 at 5:37 PM
Font : A-A+

 New Synthetic Vaccine To Protect Against Mayaro Virus Created

To stop the Mayaro Virus, the scientists from The Wistar Institute have developed synthetic DNA vaccine targeting MAYV envelope (E) protein isolated from the major circulating strains of MAYV ("scMAYV-E").

A novel, synthetic DNA vaccine developed at The Wistar Institute induces protective immunity against Mayaro virus (MAYV), a mosquito-borne infection endemic to South America, that has the potential to become a global emerging viral threat. Study results were published in PLOS Neglected Tropical Diseases.

Advertisement


Since its discovery in 1954, MAYV infections have been confined to the heavily forested areas of Trinidad and Tobago and the neighboring regions of South America. However, a reported case of MAYV infection in Haiti in 2015 and laboratory evidence suggest that multiple mosquito species can transmit MAYV, highlighting the potential for further uncontrolled expansion of MAYV into tropical regions of the Caribbean and Central and South America.

"Although MAYV was discovered a long time ago and can cause severe health complications, it remains a neglected disease and is understudied," said Kar Muthumani, Ph.D., director of the Laboratory of Emerging Infectious Diseases at The Wistar Institute and assistant professor in Wistar's Vaccine & Immunotherapy Center. "The potential for this virus to spread beyond its historical geographic range, as Zika virus did a few years ago, makes the creation of an effective immunization strategy even more pressing."
Advertisement

Similar to infections caused by dengue or chikungunya viruses, MAYV infection causes fever, rash, headache, nausea, and vomiting for prolonged periods in many people and can lead to persistent and debilitating muscle and joint pain in some patients. There are no approved treatments or preventative medicines for Mayaro fever.

In the new study, Muthumani and colleagues created a novel synthetic DNA vaccine targeting MAYV envelope (E) protein isolated from the major circulating strains of MAYV ("scMAYV-E").

The vaccine's unique design accounts for the natural genetic variability of this major viral surface antigen, and it was optimized to improve its expression in vivo. The scMAYV-E DNA vaccine was administered by intramuscular injection followed by electroporation, pulses of electricity designed to make cells more permeable to foreign DNA and enhance vaccine uptake, which allows for dose-sparing.

Immunization with scMAYV-E induced strong protective and MAYV-specific immune responses in mice, including both MAYV infection-neutralizing antibodies as well as cellular responses to multiple regions of MAYV-E. Importantly, the scMAYV-E vaccine provided complete protection from death and clinical signs of infection in a MAYV-challenge mouse model.

"The robust immunogenicity of the scMAYV-E vaccine demonstrated here supports the need for further testing of this vaccine as a viable means to halt the spread of this virus and protect individuals at risk from MAYV disease," added Muthumani. "DNA vaccines have a remarkable safety record in numerous clinical trials, can be designed and manufactured readily, and can be distributed cost-effectively, making them an important tool for combating emerging infectious diseases like MAYV especially in resource-poor settings, where they often arise."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
Emotional Healing
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chicken Pox Shigellosis Vaccination for Children Top 10 Vaccine Myths Debunked 

Recommended Reading
Higher The Dengue Infection Antibodies, Higher The Protection Against Zika
Antibodies created during Prior dengue infection could protect the body from the Zika virus, finds ....
Severity of Dengue can be Predicted Through 20 Genes
Researchers have identified 20 genes that can predict an individual's likelihood of developing a ......
Dengue Patients Should Defer from Donating Blood for 6-12 Months
Dengue and Chikungunya infected patients should not donate blood for 6-12 months. These infections ....
Dengue Virus Immunity may Offer Protection Against Zika Symptoms
Because Zika and dengue viruses are closely related, it is possible that pre-existing dengue virus ....
Chicken Pox
Chicken pox is an acute and highly contagious viral infection caused by the varicella zoster virus....
Shigellosis
Shigellosis or Bacillary Dysentery is a common cause of gastro-enteritis worldwide and can cause blo...
Top 10 Vaccine Myths Debunked
Childhood vaccination has saved many lives, yet lots more has to be done to increase awareness and e...
Vaccination for Children
Vaccines are biological products that impart immunity to the recipient. Vaccines may be live attenua...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use